NextGen: Life Sciences Class of 2025

 BioSpace is proud to present its NextGen: Class of 2025, a list of the hottest new life sciences companies in the United States.

To come up with this list, BioSpace identified companies that announced initial, seed or series A rounds between October 1, 2023, and September 30, 2024. They were then assessed using several different criteria including finance, partnerships, pipeline, growth potential and innovation until the BioSpace editorial team came up with its top 25 picks.

The impressive group of startups that make up BioSpace’s NextGen: Class of 2025 is already making an impact on the industry. Cell and gene therapies, radiopharmaceuticals and ADCs are among the products being developed by BioSpace’s 25 biotech startups to watch this year.  We will continue to keep a close eye on these companies as we move into the new year.

ARTBIO

COUR Pharmaceuticals

Diagonal Therapeutics

Firefly Bio

GondolaBio

Latigo Biotherapeutics

Marea Therapeutics

Mirador Therapeutics

OnCusp Therapeutics

Radionetics Oncology

Red Queen Therapeutics

Seaport Therapeutics

Tr1X

Clasp Therapeutics

Delphia Therapeutics

Exsilio Therapeutics

GC Therapeutics

Kenai Therapeutics

Latus Bio

Metsera

nChroma Bio

OrsoBio

Rampart Bioscience

Reunion Neuroscience

Shinobi Therapeutics

https://www.biospace.com/nextgen